| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |